[
  {
    "ts": null,
    "headline": "This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth",
    "summary": "With the tech sector coming under pressure many are looking for alternative investment areas. This pharma stock is an option worth considering.",
    "url": "https://finnhub.io/api/news?id=f5cf727a859d8e33b60e79091526db4c06f6063eb3eb92a403c72adabc104937",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769794615,
      "headline": "This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth",
      "id": 138307341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "With the tech sector coming under pressure many are looking for alternative investment areas. This pharma stock is an option worth considering.",
      "url": "https://finnhub.io/api/news?id=f5cf727a859d8e33b60e79091526db4c06f6063eb3eb92a403c72adabc104937"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push",
    "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
    "url": "https://finnhub.io/api/news?id=f4cc3bed64f6c4a0b48fb92cbb60541c7a7beff7f75cbc7fbb6460fdb65cd68c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769789304,
      "headline": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push",
      "id": 138307273,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
      "url": "https://finnhub.io/api/news?id=f4cc3bed64f6c4a0b48fb92cbb60541c7a7beff7f75cbc7fbb6460fdb65cd68c"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish?",
    "summary": "Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=dfe847db6db1580d76f5f9280d57ac466332e036f111fcba9aeb1c2da543f133",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769784066,
      "headline": "Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish?",
      "id": 138307343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=dfe847db6db1580d76f5f9280d57ac466332e036f111fcba9aeb1c2da543f133"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Roundup: Big Name Earnings",
    "summary": "Large cap tech earnings. Health insurance stocks drop. Good news in travel and leisure. Interesting new Fed Chair.",
    "url": "https://finnhub.io/api/news?id=760a48a16e5d38ec85c69d461827e030e5d63090e3f0b10f0e85d38541fb28f9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769781000,
      "headline": "Wall Street Roundup: Big Name Earnings",
      "id": 138308182,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2252783461/image_2252783461.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Large cap tech earnings. Health insurance stocks drop. Good news in travel and leisure. Interesting new Fed Chair.",
      "url": "https://finnhub.io/api/news?id=760a48a16e5d38ec85c69d461827e030e5d63090e3f0b10f0e85d38541fb28f9"
    }
  },
  {
    "ts": null,
    "headline": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
    "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
    "url": "https://finnhub.io/api/news?id=6d3235feb7809fc118260c3964811cf411a3585c4a22acc128c5826ccb345911",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769780940,
      "headline": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
      "id": 138306066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
      "url": "https://finnhub.io/api/news?id=6d3235feb7809fc118260c3964811cf411a3585c4a22acc128c5826ccb345911"
    }
  },
  {
    "ts": null,
    "headline": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
    "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
    "url": "https://finnhub.io/api/news?id=bd9854ddab8b151df0e9dd202975f68875de5e626bc8fdacf7688d03476383cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769777400,
      "headline": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
      "id": 138306183,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
      "url": "https://finnhub.io/api/news?id=bd9854ddab8b151df0e9dd202975f68875de5e626bc8fdacf7688d03476383cd"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Guardant Health Before Feb. 19?",
    "summary": "This genomics stock appears to be at an inflection point.",
    "url": "https://finnhub.io/api/news?id=cf82d65943bb3b9507243d39a3f00aef34aa003865b120190b14fd60c5e22614",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769767440,
      "headline": "Should You Buy Guardant Health Before Feb. 19?",
      "id": 138304601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "This genomics stock appears to be at an inflection point.",
      "url": "https://finnhub.io/api/news?id=cf82d65943bb3b9507243d39a3f00aef34aa003865b120190b14fd60c5e22614"
    }
  },
  {
    "ts": null,
    "headline": "Heard on the Street Thursday Recap: Gold Swings",
    "summary": "Gold prices went haywire. A 9.4 percentage point swing in gold futures prices between the intraday high and low was the largest range since April 2013, according to Dow Jones Market Data. Futures settled slightly up on the day, at a new record high.",
    "url": "https://finnhub.io/api/news?id=251bc7e49f4cedb1bf27f567fafb6c379640945ce0be196835b18c50ccb9c1a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769763089,
      "headline": "Heard on the Street Thursday Recap: Gold Swings",
      "id": 138304549,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Gold prices went haywire. A 9.4 percentage point swing in gold futures prices between the intraday high and low was the largest range since April 2013, according to Dow Jones Market Data. Futures settled slightly up on the day, at a new record high.",
      "url": "https://finnhub.io/api/news?id=251bc7e49f4cedb1bf27f567fafb6c379640945ce0be196835b18c50ccb9c1a1"
    }
  }
]